Neumora Therapeutics Inc. (NMRA)
NASDAQ: NMRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
NMRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $87.99M
- EPS (TTM)
- -$1.23
- Dividend yield
- None
- 52-week range
- 0.4519 – 3.65
- Day range
- 0.4519 – 0.4819
- Volume / Avg
- 2.75M / 1.15M
- Beta
- —
- Shares outstanding
- 187.90M
- Next earnings
- Nov 5, 2026
52-week range
NMRA stock today
On Oct 7, NMRA ended the session at $0.4683, shedding $0.0027 (0.57%), versus the S&P 500's 0.22% decline. Volume was 2.4x the average at 2.75M shares, a sign of unusually heavy trading. At this level, NMRA sits near the bottom of its 52-week range of $0.4519 to $3.65: 87.2% below the high, set on Feb 18, 2026 and 3.6% above the low.
NMRA is down 73.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 74.8%. Neumora Therapeutics has posted a net loss over the last twelve months (EPS of -$1.23), so its P/E ratio is not meaningful. Neumora Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Neumora Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2023
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.19
Neumora Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CGTXCognition Therapeutics Inc. | 0.9366 | -0.36% | $89.06M | vs NMRA |
| CRDFCardiff Oncology Inc. | 1.09 | +1.87% | $84.80M | vs NMRA |
| ATRAAtara Biotherapeutics Inc. | 9.37 | -3.90% | $94.05M | vs NMRA |
| PTHSPelthos Therapeutics Inc. | 20.99 | -2.28% | $80.36M | vs NMRA |
| GRMLGreenland Mines Ltd. | 5.83 | -8.62% | $77.81M | vs NMRA |
| OKYOOKYO Pharma Limited | 1.41 | -3.42% | $74.00M | vs NMRA |
| BDTXBlack Diamond Therapeutics Inc. | 1.83 | +1.67% | $104.86M | vs NMRA |
| CSBRChampions Oncology Inc. | 4.88 | -2.59% | $67.92M | vs NMRA |
Indexes, lists and sector
Neumora Therapeutics stock FAQ
What is Neumora Therapeutics's stock price today?
NMRA last traded at $0.4683 as of Oct 7, 4:00 PM EDT, down 0.57% on the day. Prices are delayed at least 15 minutes.
When is Neumora Therapeutics's next earnings date?
Neumora Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.19.
What is the NMRA 52-week high?
The 52-week high for NMRA is $3.65 and the 52-week low is $0.4519. The stock is currently 87.2% below its high.